Home > PJ  (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7191 p431-434
30 March 2002

This page
Reprint
Photocopy

   

PDF* 70K

Letters

  The Profession
  Community pharmacy
  FP10 switching
  CPD
  Childhood vaccination
  Homoeopathy
  Drugs of abuse
  The Conference
  The Society
  The Journal


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

FP10 switching

Can we have assurances from the PPA please?

From Mr J . S. Urwin, MRPharmS

Several years ago the design of the exemption declaration on the reverse of form FP10 was amended to incorporate spaces in which those claiming exemption while, for example, on income support could print their name, date of birth and national insurance number. As a result of this, a number of patients, perhaps elderly or partially sighted, would inadvertently sign the form in this area rather than in the correct place in Part 3. Since there is no requirement for many patients to fill in the extra details, I took the view that the patient had signed the form to claim exemption in good faith and simply drew an arrow to redirect the signature to the correct part of the form.

Several months later the Prescription Pricing Authority started informing contractors how many prescriptions had been switched from "exempt" to "paid" bundles. Contractors are effectively fined the prescription charge for each item switched. On querying the number of forms that had been switched, I learnt that unless the signature was within the boundaries of Part 3, the form was treated as unsigned and switched to the "paid" bundle.

The latest version of form FP10 has the space for the patient's signature in Part 3 enclosed in a bold box. Can the PPA assure us that a signature outside the box (but still within Part 3) will not be used as another excuse for switching prescriptions, thus generating savings at the expense of community pharmacists?

John S. Urwin
Workington, Cumbria

 

MICHAEL KING, director of planning and corporate affairs, Prescription Pricing Authority, replies:

The PPA can confirm that provided the patient or the patient's representative signs in Part 3 of any prescription form (and there is no indication that a charge or charges have been paid), the prescription will be processed for payment as exempt, ie, it will not be transferred to the chargeable group.

Further information and help on prescription switching is available on our website or by contacting our prescription switching helpline on 0191 203 5100.

 

Previous Topic (Community pharmacy)
Next Topic (Continuing professional development)
Send your letter to The Editor

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal